IScibe and Johnson & Johnson Announce Joint-Market Deal

Article

(SAN MATEO, Calif.)IScribe, Inc., a provider of electronic, hand-held prescription-writing systems for doctors, is expected to announce a joint-market deal with pharmaceutical giant Johnson & Johnson. The Johnson & Johnson sales force will promote iScribe to primary-care doctors and specialists. In exchange, Johnson & Johnson will obtain the right to sponsor advertising and health information on the system. This will include Johnson & Johnson paying a sponsorship fee that will be determined by the number of physicians using the iScribe system. For more information visit www.iscribe.com.

Recent Videos
Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
COVID-19 presentations at IDWeek in Las Angeles, California by Invivyd.   (Adobe Stock 333039083 by Production Perig)
Long COVID and Other Post-Viral Syndromes
Meet Jenny Hayes, MSN, RN, CIC, CAIP, CASSPT.
Infection Control Today Editorial Advisory Board: Fibi Attia, MD, MPH, CIC.
Andrea Thomas, PhD, DVM, MSc, BSc, director of epidemiology at BlueDot
mpox   (Adobe Stock 924156809 by Andreas Prott)
Meet Alexander Sundermann, DrPH, CIC, FAPIC.
Veterinary Infection Prevention
Related Content